HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Optimization of the MALDIxin test for the rapid identification of colistin resistance in Klebsiella pneumoniae using MALDI-TOF MS.

AbstractBACKGROUND:
With the dissemination of carbapenemase producers, a revival of colistin was observed for the treatment of infections caused by MDR Gram-negatives. Unfortunately, the increasing usage of colistin led to the emergence of resistance. In Klebsiella pneumoniae, colistin resistance arises through addition of 4-amino-l-arabinose (l-Ara4N) or phosphoethanolamine (pEtN) to the native lipid A. The underlying mechanisms involve numerous chromosome-encoded genes or the plasmid-encoded pEtN transferase MCR. Currently, detection of colistin resistance is time-consuming since it still relies on MIC determination by broth microdilution. Recently, a rapid diagnostic test based on MALDI-TOF MS detection of modified lipid A was developed (the MALDIxin test) and tested on Escherichia coli and Acinetobacter baumannii.
OBJECTIVES:
Optimize the MALDIxin test for the rapid detection of colistin resistance in K. pneumoniae.
METHODS:
This optimization consists of an additional mild-acid hydrolysis of 15 min in 1% acetic acid. The optimized method was tested on a collection of 81 clinical K. pneumoniae isolates, including 49 colistin-resistant isolates (45 with chromosome-encoded resistance, 3 with MCR-related resistance and 1 with both mechanisms).
RESULTS:
The optimized method allowed the rapid (<30 min) identification of l-Ara4N- and pEtN-modified lipid A of K. pneumoniae, which are known to be the real triggers of polymyxin resistance. At the same time, it discriminates between chromosome-encoded and MCR-related polymyxin resistance.
CONCLUSIONS:
The MALDIxin test has the potential to become an accurate tool for the rapid determination of colistin resistance in clinically relevant Gram-negative bacteria.
AuthorsLaurent Dortet, Agnieszka Broda, Sandrine Bernabeu, Youri Glupczynski, Pierre Bogaerts, Rémy Bonnin, Thierry Naas, Alain Filloux, Gerald Larrouy-Maumus
JournalThe Journal of antimicrobial chemotherapy (J Antimicrob Chemother) Vol. 75 Issue 1 Pg. 110-116 (01 01 2020) ISSN: 1460-2091 [Electronic] England
PMID31580426 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.
Chemical References
  • Anti-Bacterial Agents
  • Lipid A
  • Colistin
Topics
  • Anti-Bacterial Agents (pharmacology)
  • Colistin (pharmacology)
  • Drug Resistance, Bacterial
  • Humans
  • Klebsiella pneumoniae (drug effects)
  • Lipid A (chemistry)
  • Microbial Sensitivity Tests
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: